Recent Updates | California Health Benefits Review Program

What’s new at CHBRP?

A backdrop of palm trees silhouetted by a sunset. A sign that reads "End (of session)" is in the foreground

What happened to all the bills?

We've reached the 2025–2026 legislative finish line! Want to see how CHBRP-analyzed health bills fared? Click the banner to view final bill outcomes and post-analysis updates.

CHBRP has received a request to analyze SB 839 (Bradford): Obesity Treatment Parity Act

CHBRP has received a request from the Legislature to prepare a report centered on the ways in which California-regulated healthcare service plans and health insurers are utilizing prior authorization.

CHBRP has completed its analysis of AB 1060 (Ortega): Naloxone Hydrochloride

CHBRP has completed its analysis of AB 1048 (Wicks): Dental Benefits and Rate Review

CHBRP has completed its analysis of SB 427 (Portantino): Antiretroviral Drugs, Devices, and Products

CHBRP has completed its analysis of SB 339 (Wiener): HIV Preexposure Prophylaxis and Postexposure Prophylaxis

CHBRP has completed its analysis of AB 907 (Lowenthal): Coverage for PANDAS and PANS.

CHBRP has completed its analysis of AB 1451 (Jackson): Behavioral Health Crisis Treatment

CHBRP has completed its analysis of AB 874 (Weber): Out-of-pocket Expenses

CHBRP has completed its analysis of SB 729 (Menjivar): Treatment for Infertility and Fertility Services

CHBRP has completed its analysis of SB 1645 (Zbur): Cost Sharing

CHBRP has completed its analysis of AB 1157 (Ortega): Rehabilitative and Habilitative Services: Durable Medical Equipment and Services

CHBRP has completed its analysis of SB 694 (Eggman): Medi-Cal: Self-Measured Blood Pressure Devices and Services

CHBRP has completed its analysis of AB 1288 (Reyes): Medication-Assisted Treatment

CHBRP has completed its analysis of SB 621 (Connolly): Metabolic Disorders

CHBRP has completed its analysis of AB 716 (Boerner Horvath): Emergency Ground Medical Transportation

CHBRP has completed its analysis of SB 621 (Caballero): Biosimilar Drugs

CHBRP has completed its analysis of SB 90 (Wiener): Insulin Affordability

CHBRP has completed its analysis of SB 70 (Wiener): Prescription Drug Coverage

CHBRP has completed its analysis of AB 85 (Weber): Social Determinants of Health: Screening and Outreach

CHBRP has received a request to analyze SB 427 (Portantino): Cost Sharing and Utilization Management: Antiretroviral Drugs